Experts present the results of a retrospective analysis of patients who received IV ketamine for TRD over a timeframe of up to 2 years.
Kristina T. Kumpf, MA
Advertisement
Articles by Kristina T. Kumpf, MA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression
2
GABA Deficits and Sleep Disruption in Early Alzheimer Disease
3
Sleep Changes Across the Lifespan: A Multidimensional Construct
4
Sleep, Cognition, and the Bidirectional Brain, With Michael Scullin, PhD
5